日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Interaction Mode of the Novel Monobactam AIC499 Targeting Penicillin Binding Protein 3 of Gram-Negative Bacteria

新型单环β-内酰胺类抗生素AIC499靶向革兰氏阴性菌青霉素结合蛋白3的相互作用模式

Freischem, Stefan; Grimm, Immanuel; López-Pérez, Arancha; Willbold, Dieter; Klenke, Burkhard; Vuong, Cuong; Dingley, Andrew J; Weiergräber, Oliver H

Correction: Freischem et al. Interaction Mode of the Novel Monobactam AIC499 Targeting Penicillin Binding Protein 3 of Gram-Negative Bacteria. Biomolecules 2021, 11, 1057

更正:Freischem 等人,《新型单环β-内酰胺类抗生素 AIC499 与革兰氏阴性菌青霉素结合蛋白 3 的相互作用模式》,《生物分子》2021, 11, 1057

Freischem, Stefan; Grimm, Immanuel; López-Pérez, Arancha; Willbold, Dieter; Klenke, Burkhard; Vuong, Cuong; Dingley, Andrew J; Weiergräber, Oliver H

Discovery of Pyrrolidine-2,3-diones as Novel Inhibitors of P. aeruginosa PBP3

发现吡咯烷-2,3-二酮作为铜绿假单胞菌 PBP3 的新型抑制剂

Arancha López-Pérez, Stefan Freischem, Immanuel Grimm, Oliver Weiergräber, Andrew J Dingley, María Pascual López-Alberca, Herbert Waldmann, Waldemar Vollmer, Kamal Kumar, Cuong Vuong

Regulatory Science to 2025: An Analysis of Stakeholder Responses to the European Medicines Agency's Strategy

2025年监管科学展望:利益相关者对欧洲药品管理局战略的回应分析

Hines, Philip A; Gonzalez-Quevedo, Rosa; Lambert, Apolline I O M; Janssens, Rosanne; Freischem, Barbara; Torren Edo, Jordi; Claassen, Ivo J T M; Humphreys, Anthony J